Latest filing published 15 Dec 2023 for Cytosorbents Corp, €9,261.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Jiny Kim: trading record in brief
Jiny Kim (board member) discloses dealings in Cytosorbents Corp to SEC (Form 4). In total, 3 filings cover trades dated from 5 April 2022 to 13 December 2023.
On the market, this insider has only ever bought: 2 purchases, €11k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant. Since January 2023: 1 purchase and no sales on the market.
The newest entry dates from 15 December 2023: an open-market purchase of €9,261, in Cytosorbents Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jiny Kim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,519 shares@ US$1.3382.9% of flowCommon StockSEC:0001104659-23-126424:0Canonical exit: 12 Mar 2024 (T+90)
- 1,000 shares@ US$1.9117.1% of flowCommon StockSEC:0001104659-22-095149:0Canonical exit: 23 Nov 2022 (T+90)
- 69,300 shares0Common StockSEC:0001104659-22-042913:0
3 of 3 declarations